Abaxis

Abaxis is a medical diagnostics company that specializes in the development and manufacture of portable blood analysis systems for both human and veterinary medicine. The company's core technology, the Piccolo Xpress and VetScan systems, utilizes centrifugal microfluidics to perform complex biochemical tests in minutes using small samples of whole blood, serum, or plasma. These point-of-care devices are designed to provide lab-quality results in clinical settings, improving the speed and efficiency of patient diagnosis. The company's proprietary Orbos technology allows for the stabilization of reagents in a dry format, enabling long shelf life and ease of use. In 2018, Abaxis was acquired by Zoetis, a global leader in animal health, for approximately $2 billion to enhance its diagnostic capabilities. Today, the Abaxis product line continues to be a cornerstone of the Zoetis diagnostics portfolio.